STOCK TITAN

Eva Live Inc SEC Filings

GOAI NASDAQ

Welcome to our dedicated page for Eva Live SEC filings (Ticker: GOAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This Eva Live Inc. (GOAI) filings page provides access to the company’s public disclosures as filed with the U.S. Securities and Exchange Commission. Eva Live’s recent SEC activity includes multiple S-1/A registration statements and a Form 8-K, which together outline its proposed public offering structure, regulatory status, and certain corporate developments. Stock Titan’s tools surface these filings alongside AI-powered summaries to help explain their key points in clear language.

Eva Live’s S-1/A registration statements describe a planned offering of Units, each consisting of one share of common stock and one warrant to purchase an additional share. The prospectus language explains how the Units are structured, how the warrants are exercisable, and the role of Maxim Group LLC as sole book-running manager. These filings also state that Eva Live’s common stock is quoted on the OTCQB under the symbol “GOAI” and that the company intends to apply for listing of its common stock and warrants on the Nasdaq Capital Market under the symbols “GOAI” and “GOAIW,” while noting that there is no assurance of approval.

The S-1/A documents further identify Eva Live as a Nevada corporation with a Standard Industrial Classification code of 7370, and as both a smaller reporting company and an emerging growth company. They set out risk factor sections, offering terms, and other disclosures that are important for understanding the company’s AI-focused software and performance marketing business. Stock Titan’s AI features can highlight sections dealing with offering mechanics, warrant terms, and the implications of the company’s emerging growth company status.

Eva Live’s Form 8-K filed in September 2025 reports the appointment of an interim Chief Financial Officer and references prior work on financial strategy, audit readiness, capital markets planning, and uplisting initiatives. Through this page, users can review that 8-K and related exhibits, and use AI-generated explanations to quickly grasp the significance of management changes and other reported events. Together, the S-1/A and 8-K filings give a structured view of GOAI’s regulatory, financing, and governance disclosures.

Rhea-AI Summary

Eva Live Inc. announced the launch of “Eva Brain,” a fully autonomous AI marketing agent designed to manage and optimize digital advertising campaigns without traditional human campaign teams. The system can handle campaign creation, bid and budget optimization, audience targeting, creative generation, fraud detection, and continuous learning across platforms such as Google Ads, Meta, TikTok, Taboola, and Outbrain.

The company positions Eva Brain as a new category of autonomous marketing agents, built on its proprietary “Eva Brain stack” using large-scale data ingestion, reinforcement learning, and predictive modeling. For the year ended December 31, 2025, Eva Live reported revenue of $17,037,328, representing 82.6% year-over-year growth, and net income of $8,127,313 compared to a net loss of $(3,753,268) in 2024, alongside expansion to 20 active enterprise clients from 15 a year earlier.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.18%
Tags
current report
-
Rhea-AI Summary

Eva Live Inc. entered into an Equity Distribution Agreement with Maxim Group LLC that allows the company to sell shares of common stock with an aggregate offering price of up to $100,000,000 in an at-the-market program.

Maxim will act as sales agent, using commercially reasonable efforts to place shares, and will receive a 3.0% commission on gross proceeds, plus specified expense reimbursements. Eva Live is not required to sell any shares and the agreement can be terminated by either party on five days’ notice or upon earlier specified events. The shares are registered under an effective Form S-3 shelf registration, and net proceeds are intended for working capital and general corporate purposes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Eva Live Inc. has filed a prospectus supplement to sell up to $100,000,000 of its common stock in an at-the-market offering through Maxim Group LLC as sales agent. The plan permits sales from time to time under an Equity Distribution Agreement; Maxim will receive a 3% commission on gross proceeds.

The cover math shows 31,342,285 shares outstanding prior to this offering and, assuming sale of 25,125,628 shares at $3.98 per share, pro forma as adjusted outstanding would be up to 58,748,713 shares. The company discloses that CEO David Boulette beneficially owns approximately 63.02% of common stock. Financials show a pro forma as adjusted cash balance and capitalization reflecting the assumed proceeds; the filing also discloses a going concern qualification in prior filings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Eva Live Inc. is registering up to 8,381,375 shares of Common Stock issuable upon conversion of a secured convertible note (the Initial Note) issued under a Purchase Agreement with Streeterville Capital, LLC. The registration covers shares convertible into common stock at the Conversion Price; the Company will not receive additional cash proceeds upon conversion. Shares outstanding were 31,342,285 as of December 31, 2025, and outstanding shares following full conversion would be up to 39,723,660 assuming conversion of the Initial Note. The Initial Note had an original principal amount of $7,560,000 and was issued for gross proceeds of $7,000,000. Conversion mechanics and the conversion price are described in the Initial Note and this prospectus supplement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.56%
Tags
prospectus
-
Rhea-AI Summary

Eva Live Inc. reports a financing transaction involving a securities purchase agreement with Streeterville Capital, LLC for a secured convertible note with an aggregate original principal amount of $7,560,000. The note is convertible into Eva Live common stock.

The shares of common stock underlying this note were registered under the company’s shelf registration statement on Form S-3, which was declared effective by the SEC on March 24, 2026, and are covered by a related prospectus supplement filed on March 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.56%
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Eva Live Inc. files a shelf registration to offer up to $250,000,000 of securities from time to time, including common stock, preferred stock, depositary shares, warrants, rights and units.

The registration permits multiple offerings under a single prospectus with specific terms to be provided in prospectus supplements and contemplates sales directly, through agents, underwriters or dealers. The prospectus notes the company is an emerging growth company, lists 31,485,389 shares of common stock issued and outstanding as of March 17, 2026, and discloses going concern language in its audited financial statements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

Eva Live Inc. files its annual report describing its evolution into an AI-driven digital marketing and media monetization company operating through the Eva Platform and Eva XML Platform. The business serves mainly North American advertisers and agencies, with seventeen customers in 2025 and its top three customers providing about 61% of revenue.

The report explains a reverse recapitalization with EvaMedia, a 1-for-4 reverse stock split, and a January 2026 uplisting of its GOAI common stock to Nasdaq. Eva Live details extensive high-cost financing: multiple promissory and convertible notes with 1800 Diagonal Lending and Boot Capital carrying effective costs generally in the high-20% to near-40% range and default-triggered conversion at steep discounts, plus a $110,000 individual convertible note at a fixed $2.60 conversion price.

In February 2026, the company also entered a secured convertible note with Streeterville Capital with $7,560,000 principal and $7,000,000 gross proceeds, and the investor may buy up to an additional $4,320,000 of notes. Eva Live highlights that AI and big data are central to its campaign optimization strategy, while acknowledging intense competition in demand-side platforms and the operational and governance challenges created by rapid AI adoption. The company notes it has no operational exposure to the Russia–Ukraine or Middle East conflicts and reports no disruption to its operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

Eva Live Inc. furnished a definitive Information Statement informing holders that a stockholder owning 19,025,000 shares (60.70%) executed a written consent approving a private placement of secured convertible promissory notes and the potential issuance of up to 13,200,000 shares of Common Stock. The Information Statement was first mailed on March 9, 2026 and the actions will be effective 20 calendar days after mailing. As of the record date February 26, 2026, there were 31,342,285 shares outstanding.

The Purchase Agreement with Streeterville Capital, LLC contemplates an $7,560,000 initial note (company to receive gross proceeds of $7.0 million at closing), conversion mechanics tied to a VWAP-based Conversion Price (floor of $0.90), an original issue discount and various default and trigger provisions. The Initial Note is secured by collateral described in a Security Agreement. Stockholder approval was obtained by written consent under Nevada law and Nasdaq Listing Rule 5635(d).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
Rhea-AI Summary

Eva Live Inc. is registering up to 13,200,000 shares of Common Stock in connection with a private placement tied to secured convertible promissory notes with Streeterville Capital, LLC.

The company entered the Purchase Agreement on February 23, 2026, issuing an Initial Note with original principal $7,560,000 and expected gross proceeds of $7.0 million at Closing, plus an investor option to purchase up to $4,320,000 of Additional Notes over 24 months. Conversion uses a price equal to 87% of the lowest daily VWAP during the prior ten Trading Days, subject to a Floor Price of $0.90. Shares outstanding were 31,342,285 as of February 26, 2026, and the consenting majority stockholder, David Boulette, beneficially owns 19,025,000 shares (60.70%). The corporate actions were approved by written consent and will be effective 20 calendar days after mailing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy

FAQ

How many Eva Live (GOAI) SEC filings are available on StockTitan?

StockTitan tracks 29 SEC filings for Eva Live (GOAI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Eva Live (GOAI)?

The most recent SEC filing for Eva Live (GOAI) was filed on April 28, 2026.